These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2664391)

  • 21. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide (EDRF) enhances the vasorelaxing effect of dihydropyridine calcium antagonists in isolated human middle cerebral arteries.
    Akopov SE
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):101-4. PubMed ID: 8740241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proximal and distal dog coronary arteries respond differently to basal EDRF but not to NO.
    Hoeffner U; Boulanger C; Vanhoutte PM
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H828-31. PubMed ID: 2784288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of basal and agonist-stimulated release of endothelium-derived relaxing factor from different arteries.
    Christie MI; Griffith TM; Lewis MJ
    Br J Pharmacol; 1989 Oct; 98(2):397-406. PubMed ID: 2479439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins.
    McGrath JC; Monaghan S; Templeton AG; Wilson VG
    Br J Pharmacol; 1990 Jan; 99(1):77-86. PubMed ID: 1970495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacology of EDRF and nitric oxide on vascular strips.
    Hutchinson PJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1987 Sep; 141(3):445-51. PubMed ID: 3499329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction and atherosclerosis.
    Vanhoutte PM
    Eur Heart J; 1997 Nov; 18 Suppl E():E19-29. PubMed ID: 9402468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide: orchestrator of endothelium-dependent responses.
    Félétou M; Köhler R; Vanhoutte PM
    Ann Med; 2012 Nov; 44(7):694-716. PubMed ID: 21895549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro: possible role of Na+/Ca2+ exchange.
    Cocks TM; Little PJ; Angus JA; Cragoe EJ
    Br J Pharmacol; 1988 Sep; 95(1):67-76. PubMed ID: 3146397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic peptide inhibits the release of endothelium-derived relaxing factor from blood vessels of the rabbit.
    Hogan JC; Smith JA; Richards AC; Lewis MJ
    Eur J Pharmacol; 1989 Jun; 165(1):129-34. PubMed ID: 2527757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications.
    Feng Q; Hedner T
    Clin Physiol; 1990 Sep; 10(5):407-26. PubMed ID: 2245592
    [No Abstract]   [Full Text] [Related]  

  • 33. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
    Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
    Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide: its identity and role in blood pressure control.
    Das S; Kumar KN
    Life Sci; 1995; 57(17):1547-56. PubMed ID: 7564902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular smooth muscle sensitivity to endothelium-derived relaxing factor is different in different arteries.
    Christie MI; Lewis MJ
    Br J Pharmacol; 1988 Oct; 95(2):630-6. PubMed ID: 2852527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta.
    Ellis A; Li CG; Rand MJ
    Br J Pharmacol; 2000 Jan; 129(2):315-22. PubMed ID: 10694238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endothelial dysfunction and atherosclerosis].
    Vanhoutte PM
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():9-19. PubMed ID: 9515109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prologue: EDHF--what is it?
    Campbell WB; Harder DR
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2413-6. PubMed ID: 11356592
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.
    Shikano K; Ohlstein EH; Berkowitz BA
    Br J Pharmacol; 1987 Nov; 92(3):483-5. PubMed ID: 3501321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery.
    Dora KA; Hinton JM; Walker SD; Garland CJ
    Br J Pharmacol; 2000 Jan; 129(2):381-7. PubMed ID: 10694246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.